Cerebrospinal Fluid Levels of β-Amyloid 40 and β-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients
10.3988/jcn.2019.15.3.353
- Author:
Hyun Jae KIM
1
;
Tae Sung LIM
;
Sun Min LEE
;
Tae Sung KIM
;
Youngbin KIM
;
Young Sil AN
;
Young Chul YOUN
;
Sun Ah PARK
;
Jaerak CHANG
;
So Young MOON
Author Information
1. Department of Neurology, Ajou University School of Medicine, Suwon, Korea. symoon.bv@gmail.com
- Publication Type:Original Article
- Keywords:
Alzheimer's disease biomarkers;
idiopathic normal pressure hydrocephalus;
amyloid positron-emission tomography;
cerebrospinal fluid
- MeSH:
Alzheimer Disease;
Amyloid;
Biomarkers;
Brain;
Cerebrospinal Fluid;
Enzyme-Linked Immunosorbent Assay;
Extracellular Fluid;
Humans;
Hydrocephalus;
Metabolism;
Positron-Emission Tomography
- From:Journal of Clinical Neurology
2019;15(3):353-359
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND PURPOSE: Cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) could be misleading in idiopathic normal-pressure hydrocephalus (iNPH). We therefore investigated the CSF biomarkers in 18F-florbetaben amyloid-negative positron-emission tomography (PET) [amyloid PET(−)] iNPH, amyloid-positive PET [amyloid PET(+)] AD, and cognitively normal (CN) subjects. METHODS: Ten amyloid PET(+) AD patients (56.7±5.6 years old, mean±standard deviation), 10 amyloid PET(−) iNPH patients (72.8±4.5 years old), and 8 CN subjects (61.2±6.5 years old) were included. We measured the levels of β-amyloid (Aβ)40, Aβ42, total tau (t-tau) protein, and phosphorylated tau (p-tau) protein in the CSF using enzyme-linked immunosorbent assays. RESULTS: The level of Aβ42 and the Aβ42/Aβ40 ratio in the CSF were significantly lower in AD than in iNPH or CN subjects. The Aβ40 level did not differ significantly between AD and iNPH (p=1.000), but it did between AD and CN subjects (p=0.032). The levels of both t-tau and p-tau were higher in AD than in iNPH or CN subjects. The levels of Aβ42, Aβ40, t-tau, and p-tau were lower in iNPH than in CN subjects, but there was no significant difference after controlling for age. CONCLUSIONS: Our results suggest that the mechanism underlying low CSF Aβ levels differs between amyloid PET(−) iNPH and amyloid PET(+) AD subjects. The lower levels of all CSF biomarkers in iNPH patients might be due to reduced clearances from extracellular fluid and decreased brain metabolism of the periventricular zone in iNPH resulting from glymphatic dysfunction.
